QbD Group
    White Paper

    Mobile health on the rise: exploring the regulatory landscape for reimbursement

    This whitepaper will help you navigate the maze of the DTx regulatory environment, highlighting several important countries and regulations.

    2024年12月11日

    关于本白皮书

    本资源涵盖的关键主题

    For DTx solutions to be integrated into mainstream healthcare, they must secure health authority (HA) approval. In certain scenarios, if the solution offers considerable societal benefits, HAs might even permit DTx to be prescribed by healthcare professionals and, depending on the country, offer reimbursement.

    This whitepaper will help you navigate the intricate maze of the current DTx regulatory environment, highlighting several important countries and regulations.

    分享本文

    QbD Group

    Need expert guidance?

    准备加速您的生命科学项目?与我们的专家交流。

    获取专家指导 →

    继续阅读

    相关内容

    我们使用 Cookie 来改善您的体验

    我们使用必要的 Cookie 来保证网站功能,以及可选的分析 Cookie 来改善我们的服务。 阅读我们的 隐私政策Cookie 政策.